TRiP research group

TRiP

Dr. Juliane Müller, MD
Psychiatrist
Research Fellow

Research interests/ Focus of work:
Early phase clinical trials, Innovative treatments for psychiatric disorders,
Neurobiology of emotion regulation

juliane_mueller
 
Academic Education:
2001–2004 Study of Medicine, University of Regensburg
2004–2008 Study of Medicine, Ludwig-Maximillians-University Munich
2008 Medical license
 
Doctoral thesis:
2015 "Tryptophanhydroxylase isoenzymes 1 and 2 in the human brain: regional distribution and potential alterations in psychiatric disorders.", Ludwig-Maximillians-University Munich
 
Board certificates:
2016 Psychiatry and Psychotherapy
 
Professional experience:
2008–2010 Resident in Psychiatry and Psychotherapy, Dept. of Psychiatry and Psychotherapy, Johann-Wolfgang Goethe University Frankfurt (Director: Prof. Dr. H. Hampel)
2010–2016 Resident in Psychiatry and Psychotherapy, Dept. of Psychiatry and Psychotherapy, Central Institute of Mental Health (Director: Prof. Dr. A. Meyer-Lindenberg)
thereof 2012-2013 Resident in Neurology, Department of Neurology, University Hospital Heidelberg (Director: Prof. Dr. W. Wick)
since 2016 Specialist and Research Fellow, Dept. of Psychiatry and Psychotherapy, Central Institute of Mental Health

 
Publications:
2016
J. K. Mueller, C. Rohleder, F. M. Leweke: What is the promise of nicotinergic compounds in schizophrenia treatment? Future Med Chem, in press
2016
F. M. Leweke, J. K. Mueller, B. Lange, C. Rohleder: Therapeutic potential of cannabinoids in psychosis. Biol Psychiatry 79:604-612
2015
E. G. Severance, K. L. Gressitt, A. Alaedini, C. Rohleder, F. Enning, J. M. Bumb, J. K. Mueller, E. Schwarz, R. H. Yolken, F. M. Leweke: IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain Behav Immun 44, 148-58.
2014
C. Schaefer*, F. Enning*, J. K. Mueller*, J. M. Bumb*, C. Rohleder, T. M. Odorfer, J. Klosterkotter, M. Hellmich, D. Koethe, C. Schmahl, M. Bohus, F. M. Leweke: Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. Eur Arch Psychiatry Clin Neurosci 264:459-463.
2009
P. Zill, A. Buttner, W. Eisenmenger, J. Muller, H. J. Moller, B. Bondy: Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain. Neuroscience 159:1274-1282.